Innoviva is fueling healthcare innovation by investing in areas of high unmet medical need as well as developing and commercializing differentiated therapies.
We are a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform, and a portfolio of strategic investments in healthcare assets.
Strongly cashflow-positive, durable core royalty business stemming from widely used respiratory products
Commercial stage, fast-growth critical care and infectious disease platform
High-potential, valuable diversified portfolio of healthcare assets offers optionality, downside protection, and long-term value creation
Thoughtful, robust approach to capital deployment with long-term horizon
Strong track record and value creation focus
© 2026 Innoviva. All rights reserved. Terms & Conditions | Privacy Policy | Contact
Sitemap | Terms & Conditions | Privacy Policy | Contact
© 2022 Innoviva. All rights reserved.
